31% of Clinical Trial Sites Report Delays From Document Inconsistencies
31% of clinical trial sites report document inconsistencies causing start-up delays that push activation timelines back by weeks.
Adaptive Clinical Trial Design Adaptive Trial Design AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies DOGE FDA Budget Cuts dual diagnosis eClinical Tech News eClinical Technology EMA Executive Interviews FDA Approval FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
31% of clinical trial sites report document inconsistencies causing start-up delays that push activation timelines back by weeks.
Eledon's Phase 3 kidney transplant trial opens with tegoprubart targeting non-inferiority to tacrolimus in rejection prevention and graft survival.
Cardiff Oncology's onvansertib Phase 2 data demonstrates 21-month durability in metastatic colorectal cancer, with median PFS not yet reached...
The Path to Prevention trial embeds Phase 2A learning cohorts inside PPMI's 7,755-participant infrastructure, here's what that means for...
A 6-year-old died after an unreported gene-editing trial at Shanghai Xinhua Hospital. With 1,033 CGT IITs active in China,...
At the FDA and Duke-Margolis rare disease workshop, a statistician unpacked what a one-sided 0.025 actually commits you to:...
FDA guidance requires CNS trial assessments classified as in-person or remote before enrollment, with no case-by-case changes allowed during...
Capricor files Q3 2026 results ahead of deramiocel FDA decision on November 22 for its Duchenne muscular dystrophy cell...
Regulatory certification of trial supply vendors doesn't prevent enrollment gaps. Here's where the operational oversight breaks down, and what...
A Nature Medicine deep learning model predicts 12+ multisystem health phenotypes from gait alone, exposing a critical blind spot...